{
  "DOI": "10.1007/s10689-023-00349-w",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-023-00349-w",
  "alternative-id": [
    "349"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "9 July 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "24 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "16 November 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "At the Genoa center, no specific ethics approval was required for this study as, by providing their written consent to be included in the Ligurian \u003ci\u003eBRCA\u003c/i\u003e registry, individuals gave permission to retrieve information from their clinical records for research purposes related to HBOC. The Ligurian \u003ci\u003eBRCA\u003c/i\u003e registry was approved by the Ligurian Ethics Committee (approval n. 002REG2017). At the Bologna center, theREGIO (Registro mono-istituzionale di individui sottoposti a valutazione del rischio genetico oncologico) Registry was approved by the CEAVEC Ethics Board (approval n.272/2022/Oss/AOUBo, 14th April 2022)."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Eva Blondeaux reports research grant (to the Institution) from Gilead Science outside the submitted work. All the other authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Trevisan",
      "given": "Lucia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Godino",
      "given": "Lea",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Battistuzzi",
      "given": "Linda",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Innella",
      "given": "Giovanni",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Luppi",
      "given": "Elena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buzzatti",
      "given": "Giulia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gismondi",
      "given": "Viviana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Blondeaux",
      "given": "Eva",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bonelli",
      "given": "Luigina Ada",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Turchetti",
      "given": "Daniela",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Varesco",
      "given": "Liliana",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        11,
        16
      ]
    ],
    "date-time": "2023-11-16T03:01:27Z",
    "timestamp": 1700103687000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        16
      ]
    ],
    "date-time": "2023-11-16T03:08:22Z",
    "timestamp": 1700104102000
  },
  "funder": [
    {
      "DOI": "10.13039/501100003196",
      "doi-asserted-by": "crossref",
      "name": "Italian Ministry of Health"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        1
      ]
    ],
    "date-time": "2024-03-01T03:46:21Z",
    "timestamp": 1709264781651
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2023,
        11,
        16
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            16
          ]
        ],
        "date-time": "2023-11-16T00:00:00Z",
        "timestamp": 1700092800000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            16
          ]
        ],
        "date-time": "2023-11-16T00:00:00Z",
        "timestamp": 1700092800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00349-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-023-00349-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00349-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        11,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        11,
        16
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s12282-020-01148-2",
      "author": "R Yoshida",
      "doi-asserted-by": "publisher",
      "first-page": "1167",
      "journal-title": "Breast Cancer",
      "key": "349_CR1",
      "unstructured": "Yoshida R (2021) Hereditary breast and Ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28:1167–1180. https://doi.org/10.1007/s12282-020-01148-2",
      "volume": "28",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jama.2017.7112",
      "author": "KB Kuchenbaecker",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "journal-title": "JAMA",
      "key": "349_CR2",
      "unstructured": "Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral Breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402. https://doi.org/10.1001/jama.2017.7112",
      "volume": "317",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.20.00046",
      "author": "VN Giri",
      "doi-asserted-by": "publisher",
      "first-page": "2798",
      "journal-title": "J Clin Oncol",
      "key": "349_CR3",
      "unstructured": "Giri VN, Knudsen KE, Kelly WK et al (2020) Implementation of germline testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol 38:2798–2811. https://doi.org/10.1200/JCO.20.00046",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.eururo.2019.08.019",
      "author": "EC Page",
      "doi-asserted-by": "publisher",
      "first-page": "831",
      "journal-title": "Eur Urol",
      "key": "349_CR4",
      "unstructured": "Page EC, Bancroft EK, Brook MN et al (2019) Interim results from the IMPACT Study: evidence for prostate-specific Antigen Screening in BRCA2 mutation carriers. Eur Urol 76:831–842. https://doi.org/10.1016/j.eururo.2019.08.019",
      "volume": "76",
      "year": "2019"
    },
    {
      "key": "349_CR5",
      "unstructured": "NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2024)"
    },
    {
      "DOI": "10.1001/jama.2014.12483",
      "author": "M-C King",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "journal-title": "JAMA",
      "key": "349_CR6",
      "unstructured": "King M-C, Levy-Lahad E, Lahad A (2014) Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312:1091–1092. https://doi.org/10.1001/jama.2014.12483",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.7326/M22-0846",
      "author": "GF Guzauskas",
      "doi-asserted-by": "publisher",
      "first-page": "585",
      "journal-title": "Ann Intern Med",
      "key": "349_CR7",
      "unstructured": "Guzauskas GF, Garbett S, Zhou Z et al (2023) Population genomic screening for three Common Hereditary conditions: a cost-effectiveness analysis. Ann Intern Med 176:585–595. https://doi.org/10.7326/M22-0846",
      "volume": "176",
      "year": "2023"
    },
    {
      "DOI": "10.1200/JCO.19.02010",
      "author": "K Offit",
      "doi-asserted-by": "publisher",
      "first-page": "1398",
      "journal-title": "J Clin Oncol",
      "key": "349_CR8",
      "unstructured": "Offit K, Tkachuk KA, Stadler ZK et al (2020) Cascading after Peridiagnostic Cancer Genetic Testing: an alternative to Population-based screening. J Clin Oncol 38:1398–1408. https://doi.org/10.1200/JCO.19.02010",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1200/JCO.20.00140",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "journal-title": "J Clin Oncol",
      "key": "349_CR9",
      "unstructured": "Kurian AW, Katz SJ (2020) Emerging opportunity of Cascade Genetic Testing for Population-wide Cancer Prevention and Control. J Clin Oncol 38:1371–1374. https://doi.org/10.1200/JCO.20.00140",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.2147/CMAR.S189627",
      "author": "C Forbes",
      "doi-asserted-by": "publisher",
      "first-page": "2321",
      "journal-title": "Cancer Manag Res",
      "key": "349_CR10",
      "unstructured": "Forbes C, Fayter D, de Kock S, Quek RG (2019) A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated Breast cancer. Cancer Manag Res 11:2321–2337. https://doi.org/10.2147/CMAR.S189627",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.annonc.2022.10.004",
      "author": "C Sessa",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "journal-title": "Ann Oncol",
      "key": "349_CR11",
      "unstructured": "Sessa C, Balmaña J, Bober SL et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol 34:33–47. https://doi.org/10.1016/j.annonc.2022.10.004",
      "volume": "34",
      "year": "2023"
    },
    {
      "DOI": "10.1200/JCO.22.00303",
      "author": "MK Frey",
      "doi-asserted-by": "publisher",
      "first-page": "4129",
      "journal-title": "J Clin Oncol",
      "key": "349_CR12",
      "unstructured": "Frey MK, Ahsan MD, Bergeron H et al (2022) Cascade Testing for Hereditary Cancer syndromes: should we move toward direct relative contact? A systematic review and Meta-analysis. J Clin Oncol 40:4129–4143. https://doi.org/10.1200/JCO.22.00303",
      "volume": "40",
      "year": "2022"
    },
    {
      "DOI": "10.1200/PO.21.00163",
      "author": "KD Whitaker",
      "doi-asserted-by": "publisher",
      "first-page": "1387",
      "journal-title": "JCO Precis Oncol",
      "key": "349_CR13",
      "unstructured": "Whitaker KD, Obeid E, Daly MB, Hall MJ (2021) Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention. JCO Precis Oncol 5:1387–1396. https://doi.org/10.1200/PO.21.00163",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10689-013-9636-9",
      "author": "FH Menko",
      "doi-asserted-by": "publisher",
      "first-page": "319",
      "journal-title": "Fam Cancer",
      "key": "349_CR14",
      "unstructured": "Menko FH, Aalfs CM, Henneman L et al (2013) Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 12:319–324. https://doi.org/10.1007/s10689-013-9636-9",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41431-020-00723-7",
      "author": "ML Di Pietro",
      "doi-asserted-by": "publisher",
      "first-page": "250",
      "journal-title": "Eur J Hum Genet",
      "key": "349_CR15",
      "unstructured": "Di Pietro ML, Zaçe D, Orfino A et al (2021) Intrafamilial communication of hereditary breast and Ovarian cancer genetic information in Italian women: towards a personalised approach. Eur J Hum Genet 29:250–261. https://doi.org/10.1038/s41431-020-00723-7",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.3390/curroncol29040203",
      "author": "G Ongaro",
      "doi-asserted-by": "publisher",
      "first-page": "2490",
      "journal-title": "Curr Oncol",
      "key": "349_CR16",
      "unstructured": "Ongaro G, Petrocchi S, Calvello M et al (2022) Psychological determinants of men’s adherence to Cascade Screening for BRCA1/2. Curr Oncol 29:2490–2503. https://doi.org/10.3390/curroncol29040203",
      "volume": "29",
      "year": "2022"
    },
    {
      "DOI": "10.1002/cam4.2824",
      "author": "L Cortesi",
      "doi-asserted-by": "publisher",
      "first-page": "2579",
      "journal-title": "Cancer Med",
      "key": "349_CR17",
      "unstructured": "Cortesi L, Baldassarri B, Ferretti S et al (2020) A regional population-based hereditary Breast cancer screening tool in Italy: first 5-year results. Cancer Med 9:2579–2589. https://doi.org/10.1002/cam4.2824",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-018-0262-8",
      "author": "L Godino",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "journal-title": "Eur J Hum Genet",
      "key": "349_CR18",
      "unstructured": "Godino L, Turchetti D, Jackson L et al (2019) Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents. Eur J Hum Genet 27:291–299. https://doi.org/10.1038/s41431-018-0262-8",
      "volume": "27",
      "year": "2019"
    },
    {
      "author": "N Cody",
      "first-page": "140",
      "journal-title": "Ir Med J",
      "key": "349_CR19",
      "unstructured": "Cody N, Green A, McDevitt T, Lynch SA (2008) Cascade screening in BRCA1/2 mutation carriers. Ir Med J 101:140–142",
      "volume": "101",
      "year": "2008"
    },
    {
      "DOI": "10.4143/crt.2020.364",
      "author": "GW Jeong",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Cancer Res Treat",
      "key": "349_CR20",
      "unstructured": "Jeong GW, Shin W, Lee DO et al (2021) Uptake of family-specific mutation genetic testing among relatives of patients with Ovarian Cancer with BRCA1 or BRCA2 mutation. Cancer Res Treat 53:207–211. https://doi.org/10.4143/crt.2020.364",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1002/1099-1611(200011/12)9:6\u003c504::aid-pon491\u003e3.0.co;2-r",
      "author": "C Julian-Reynier",
      "doi-asserted-by": "publisher",
      "first-page": "504",
      "journal-title": "Psychooncology",
      "key": "349_CR21",
      "unstructured": "Julian-Reynier C, Sobol H, Sévilla C et al (2000) Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psychooncology 9:504–510. https://doi.org/10.1002/1099-1611(200011/12)9:6\u003c504::aid-pon491\u003e3.0.co;2-r",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s10689-009-9313-1",
      "author": "J Sanz",
      "doi-asserted-by": "publisher",
      "first-page": "297",
      "journal-title": "Fam Cancer",
      "key": "349_CR22",
      "unstructured": "Sanz J, Ramón y Cajal T, Torres A et al (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer 9:297–304. https://doi.org/10.1007/s10689-009-9313-1",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1038/gim.2018.26",
      "author": "S Lieberman",
      "doi-asserted-by": "publisher",
      "first-page": "1446",
      "journal-title": "Genet Med",
      "key": "349_CR23",
      "unstructured": "Lieberman S, Lahad A, Tomer A et al (2018) Familial communication and cascade testing among relatives of BRCA population screening participants. Genet Med 20:1446–1454. https://doi.org/10.1038/gim.2018.26",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1002/pon.5169",
      "author": "FB Gauna Cristaldo",
      "doi-asserted-by": "publisher",
      "first-page": "1894",
      "journal-title": "Psychooncology",
      "key": "349_CR24",
      "unstructured": "Gauna Cristaldo FB, Touzani R, Apostolidis T et al (2019) Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France. Psychooncology 28:1894–1900. https://doi.org/10.1002/pon.5169",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1111/tbj.13633",
      "author": "S Hesse-Biber",
      "doi-asserted-by": "publisher",
      "first-page": "734",
      "journal-title": "Breast J",
      "key": "349_CR25",
      "unstructured": "Hesse-Biber S, Dwyer AA, Yi S (2020) Parent of origin differences in psychosocial burden and approach to BRCA risk management. Breast J 26:734–738. https://doi.org/10.1111/tbj.13633",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.3390/cancers12082316",
      "author": "AA Dwyer",
      "doi-asserted-by": "publisher",
      "first-page": "2316",
      "journal-title": "Cancers (Basel)",
      "key": "349_CR26",
      "unstructured": "Dwyer AA, Hesse-Biber S, Flynn B, Remick S (2020) Parent of Origin effects on Family Communication of risk in BRCA + women: a qualitative investigation of human factors in Cascade Screening. Cancers (Basel) 12:2316. https://doi.org/10.3390/cancers12082316",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1089/gte.2007.0037",
      "author": "E Finlay",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Genet Test",
      "key": "349_CR27",
      "unstructured": "Finlay E, Stopfer JE, Burlingame E et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91. https://doi.org/10.1089/gte.2007.0037",
      "volume": "12",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41431-017-0030-1",
      "author": "L Godino",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "journal-title": "Eur J Hum Genet",
      "key": "349_CR28",
      "unstructured": "Godino L, Jackson L, Turchetti D et al (2018) Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study. Eur J Hum Genet 26:44–53. https://doi.org/10.1038/s41431-017-0030-1",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1111/ecc.13083",
      "author": "L Battistuzzi",
      "doi-asserted-by": "publisher",
      "first-page": "e13083",
      "journal-title": "Eur J Cancer Care (Engl)",
      "key": "349_CR29",
      "unstructured": "Battistuzzi L, Franiuk M, Kasparian N et al (2019) A qualitative study on decision-making about BRCA1/2 testing in Italian women. Eur J Cancer Care (Engl) 28:e13083. https://doi.org/10.1111/ecc.13083",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.3390/jpm12081249",
      "author": "C Pedrazzani",
      "doi-asserted-by": "publisher",
      "first-page": "1249",
      "journal-title": "J Pers Med",
      "key": "349_CR30",
      "unstructured": "Pedrazzani C, Aceti M, Schweighoffer R et al (2022) The communication chain of genetic risk: analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary breast and Ovarian Cancer. J Pers Med 12:1249. https://doi.org/10.3390/jpm12081249",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.3390/jpm12101740",
      "author": "M Sarki",
      "doi-asserted-by": "publisher",
      "first-page": "1740",
      "journal-title": "J Pers Med",
      "key": "349_CR31",
      "unstructured": "Sarki M, Ming C, Aceti M et al (2022) Relatives from Hereditary breast and Ovarian Cancer and Lynch Syndrome families forgoing genetic testing: findings from the Swiss CASCADE cohort. J Pers Med 12:1740. https://doi.org/10.3390/jpm12101740",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.3390/cancers14071636",
      "author": "M Sarki",
      "doi-asserted-by": "publisher",
      "first-page": "1636",
      "journal-title": "Cancers (Basel)",
      "key": "349_CR32",
      "unstructured": "Sarki M, Ming C, Aissaoui S et al (2022) Intention to inform relatives, Rates of Cascade Testing, and preference for patient-mediated communication in families concerned with Hereditary breast and Ovarian Cancer and Lynch Syndrome: the Swiss CASCADE cohort. Cancers (Basel) 14:1636. https://doi.org/10.3390/cancers14071636",
      "volume": "14",
      "year": "2022"
    },
    {
      "DOI": "10.1002/jgc4.1767",
      "author": "FH Menko",
      "doi-asserted-by": "publisher",
      "journal-title": "J Genet Couns",
      "key": "349_CR33",
      "unstructured": "Menko FH, van der Velden SL, Griffioen DN et al (2023) Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. https://doi.org/10.1002/jgc4.1767",
      "year": "2023"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-3153904/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-023-00349-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy"
}